Breast Cancer

32 Expert Conversations

    32 Expert Conversations
    Breast cancer hormone therapy. LHRH agonists. Tamoxifen. SERDs. Aromatase inhibitors. SERMs. 4
    Dr. Marc Lippman. Breast Cancer hormone therapy expert. Biography. 0
    Breast cancer hormone therapy. LHRH agonists or bilateral salpingo-oophorectomy (BSO)? 9
    Immunotherapy in breast cancer. Immunotherapy is not a magic treatment. 11
    Breast cancer treatment. How to select neoadjuvant and adjuvant chemotherapy? 10
    Breast cancer hormone therapy. Opposing progestins to prevent or treat breast cancer? 7
    When can breast cancer be considered cured? Is cure possible for breast cancer? 5
    Hormone therapy for breast cancer. History and advances. 1
    Breast cancer immunotherapy. Triple-negative breast cancer. Antibody-drug conjugates. 6
    Breast cancer hormone therapy. Tamoxifen vs. Anastrozole? 3
    Breast cancer hormone therapy. How to choose aromatase inhibitors? 8
    Breast cancer hormone therapy. 5 or 10 years for Aromatase inhibitors? Estrogens promote breast cancer. 6
    How to prevent 70% of breast cancers? Tamoxifen. Aromatase inhibitors. 2
    Hormonal treatment of breast cancer. Professor Marc E. Lippman.
    Seek second opinion from a clinical physician or surgeon. Not from a radiologist. 15
    Breast cancer, obesity, and insulin. How metformin helps to delay cancer. 3
    Hormone-resistant breast cancer. New endocrine therapy of cancer. 2
    How to prevent breast cancer? Chemoprevention with aromatase inhibitors. 10
    Early breast cancer, DCIS. How to decide on best therapy? 3
    Tumor markers in DCIS breast cancer. Prediction of endocrine treatment and radiotherapy. 2
    Ductal Carcinoma In Situ, DCIS. Treatment and prevention. 1
    ‘You must give the patient a human touch.’ Top breast cancer expert shares wisdom. 10
    Metastatic triple-negative breast cancer. Long-term survival. Clinical case. 9
    Future in breast cancer therapy. Deescalation of treatment. Cure of metastatic cancer? 8
    Immunotherapy side effects in breast cancer patients. 7
    Triple-negative breast cancer therapy. Neoadjuvant therapy indications. 5
    HER2-positive breast cancer therapy. Tucatinib. Trastuzumab deruxtecan. 4
    Hormone-positive, 
HER2-negative breast cancer. Antibody-drug conjugates. 3
    Precision medicine in breast cancer therapy. Targeted drugs 
or chemotherapy? 2
    Targeted therapy for breast cancer. What are the molecular targets of drugs? 1
    Dr. Giuseppe Curigliano. Breast cancer therapy expert. Biography. 0
    Locally recurrent breast cancer treatment. 6
    Recently viewed Expert Conversations